nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—SLC22A6—Captopril—systemic scleroderma	0.445	0.76	CbGbCtD
Vancomycin—SLC22A6—Methotrexate—systemic scleroderma	0.141	0.24	CbGbCtD
Vancomycin—Vertigo—Leflunomide—systemic scleroderma	0.000888	0.00214	CcSEcCtD
Vancomycin—Insomnia—Captopril—systemic scleroderma	0.000885	0.00214	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000885	0.00214	CcSEcCtD
Vancomycin—Abdominal pain—Mometasone—systemic scleroderma	0.000881	0.00213	CcSEcCtD
Vancomycin—Body temperature increased—Mometasone—systemic scleroderma	0.000881	0.00213	CcSEcCtD
Vancomycin—Chills—Lisinopril—systemic scleroderma	0.000875	0.00211	CcSEcCtD
Vancomycin—Palpitations—Leflunomide—systemic scleroderma	0.000873	0.00211	CcSEcCtD
Vancomycin—Dyspnoea—Captopril—systemic scleroderma	0.000872	0.00211	CcSEcCtD
Vancomycin—Anaemia—Mycophenolic acid—systemic scleroderma	0.000871	0.0021	CcSEcCtD
Vancomycin—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00087	0.0021	CcSEcCtD
Vancomycin—Dizziness—Pentoxifylline—systemic scleroderma	0.000854	0.00206	CcSEcCtD
Vancomycin—Malnutrition—Lisinopril—systemic scleroderma	0.000849	0.00205	CcSEcCtD
Vancomycin—Erythema—Lisinopril—systemic scleroderma	0.000849	0.00205	CcSEcCtD
Vancomycin—Infection—Azathioprine—systemic scleroderma	0.000848	0.00205	CcSEcCtD
Vancomycin—Vertigo—Mycophenolic acid—systemic scleroderma	0.000847	0.00205	CcSEcCtD
Vancomycin—Fatigue—Captopril—systemic scleroderma	0.000844	0.00204	CcSEcCtD
Vancomycin—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000842	0.00203	CcSEcCtD
Vancomycin—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00084	0.00203	CcSEcCtD
Vancomycin—Constipation—Captopril—systemic scleroderma	0.000837	0.00202	CcSEcCtD
Vancomycin—Flatulence—Lisinopril—systemic scleroderma	0.000837	0.00202	CcSEcCtD
Vancomycin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000836	0.00202	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000836	0.00202	CcSEcCtD
Vancomycin—Palpitations—Mycophenolic acid—systemic scleroderma	0.000833	0.00201	CcSEcCtD
Vancomycin—Skin disorder—Azathioprine—systemic scleroderma	0.00083	0.002	CcSEcCtD
Vancomycin—Back pain—Lisinopril—systemic scleroderma	0.000821	0.00198	CcSEcCtD
Vancomycin—Vomiting—Pentoxifylline—systemic scleroderma	0.000821	0.00198	CcSEcCtD
Vancomycin—Muscle spasms—Lisinopril—systemic scleroderma	0.000816	0.00197	CcSEcCtD
Vancomycin—Rash—Pentoxifylline—systemic scleroderma	0.000814	0.00197	CcSEcCtD
Vancomycin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000813	0.00196	CcSEcCtD
Vancomycin—Headache—Pentoxifylline—systemic scleroderma	0.000809	0.00195	CcSEcCtD
Vancomycin—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000809	0.00195	CcSEcCtD
Vancomycin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000807	0.00195	CcSEcCtD
Vancomycin—Infection—Leflunomide—systemic scleroderma	0.000801	0.00193	CcSEcCtD
Vancomycin—Gastrointestinal pain—Captopril—systemic scleroderma	0.0008	0.00193	CcSEcCtD
Vancomycin—Asthenia—Mometasone—systemic scleroderma	0.000799	0.00193	CcSEcCtD
Vancomycin—Hypotension—Azathioprine—systemic scleroderma	0.000798	0.00193	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000797	0.00192	CcSEcCtD
Vancomycin—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00192	CcSEcCtD
Vancomycin—Nervous system disorder—Leflunomide—systemic scleroderma	0.000791	0.00191	CcSEcCtD
Vancomycin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00079	0.00191	CcSEcCtD
Vancomycin—Pruritus—Mometasone—systemic scleroderma	0.000788	0.0019	CcSEcCtD
Vancomycin—Tachycardia—Leflunomide—systemic scleroderma	0.000787	0.0019	CcSEcCtD
Vancomycin—Anaemia—Lisinopril—systemic scleroderma	0.000785	0.0019	CcSEcCtD
Vancomycin—Skin disorder—Leflunomide—systemic scleroderma	0.000783	0.00189	CcSEcCtD
Vancomycin—Abdominal pain—Captopril—systemic scleroderma	0.000774	0.00187	CcSEcCtD
Vancomycin—Body temperature increased—Captopril—systemic scleroderma	0.000774	0.00187	CcSEcCtD
Vancomycin—Nausea—Pentoxifylline—systemic scleroderma	0.000767	0.00185	CcSEcCtD
Vancomycin—Chills—Mycophenolate mofetil—systemic scleroderma	0.000767	0.00185	CcSEcCtD
Vancomycin—Infection—Mycophenolic acid—systemic scleroderma	0.000764	0.00185	CcSEcCtD
Vancomycin—Vertigo—Lisinopril—systemic scleroderma	0.000763	0.00184	CcSEcCtD
Vancomycin—Hypokalaemia—Prednisone—systemic scleroderma	0.000762	0.00184	CcSEcCtD
Vancomycin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000755	0.00182	CcSEcCtD
Vancomycin—Hypotension—Leflunomide—systemic scleroderma	0.000754	0.00182	CcSEcCtD
Vancomycin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000753	0.00182	CcSEcCtD
Vancomycin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000751	0.00181	CcSEcCtD
Vancomycin—Palpitations—Lisinopril—systemic scleroderma	0.00075	0.00181	CcSEcCtD
Vancomycin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000747	0.0018	CcSEcCtD
Vancomycin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000744	0.0018	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000742	0.00179	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000737	0.00178	CcSEcCtD
Vancomycin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000733	0.00177	CcSEcCtD
Vancomycin—Insomnia—Leflunomide—systemic scleroderma	0.000729	0.00176	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000723	0.00175	CcSEcCtD
Vancomycin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00072	0.00174	CcSEcCtD
Vancomycin—Dyspnoea—Leflunomide—systemic scleroderma	0.000719	0.00174	CcSEcCtD
Vancomycin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000719	0.00174	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000718	0.00173	CcSEcCtD
Vancomycin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00173	CcSEcCtD
Vancomycin—Vomiting—Mometasone—systemic scleroderma	0.000708	0.00171	CcSEcCtD
Vancomycin—Rash—Mometasone—systemic scleroderma	0.000703	0.0017	CcSEcCtD
Vancomycin—Asthenia—Captopril—systemic scleroderma	0.000702	0.0017	CcSEcCtD
Vancomycin—Dermatitis—Mometasone—systemic scleroderma	0.000702	0.00169	CcSEcCtD
Vancomycin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000698	0.00169	CcSEcCtD
Vancomycin—Headache—Mometasone—systemic scleroderma	0.000698	0.00169	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000696	0.00168	CcSEcCtD
Vancomycin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000696	0.00168	CcSEcCtD
Vancomycin—Fatigue—Leflunomide—systemic scleroderma	0.000695	0.00168	CcSEcCtD
Vancomycin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000693	0.00167	CcSEcCtD
Vancomycin—Pruritus—Captopril—systemic scleroderma	0.000692	0.00167	CcSEcCtD
Vancomycin—Pain—Leflunomide—systemic scleroderma	0.00069	0.00167	CcSEcCtD
Vancomycin—Constipation—Leflunomide—systemic scleroderma	0.00069	0.00167	CcSEcCtD
Vancomycin—Infection—Lisinopril—systemic scleroderma	0.000689	0.00166	CcSEcCtD
Vancomycin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000688	0.00166	CcSEcCtD
Vancomycin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000686	0.00166	CcSEcCtD
Vancomycin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000679	0.00164	CcSEcCtD
Vancomycin—Neutropenia—Prednisone—systemic scleroderma	0.000677	0.00163	CcSEcCtD
Vancomycin—Tachycardia—Lisinopril—systemic scleroderma	0.000676	0.00163	CcSEcCtD
Vancomycin—Body temperature increased—Azathioprine—systemic scleroderma	0.000675	0.00163	CcSEcCtD
Vancomycin—Abdominal pain—Azathioprine—systemic scleroderma	0.000675	0.00163	CcSEcCtD
Vancomycin—Skin disorder—Lisinopril—systemic scleroderma	0.000673	0.00163	CcSEcCtD
Vancomycin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00161	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000664	0.0016	CcSEcCtD
Vancomycin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000663	0.0016	CcSEcCtD
Vancomycin—Nausea—Mometasone—systemic scleroderma	0.000662	0.0016	CcSEcCtD
Vancomycin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00066	0.00159	CcSEcCtD
Vancomycin—Pain—Mycophenolic acid—systemic scleroderma	0.000658	0.00159	CcSEcCtD
Vancomycin—Constipation—Mycophenolic acid—systemic scleroderma	0.000658	0.00159	CcSEcCtD
Vancomycin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000658	0.00159	CcSEcCtD
Vancomycin—Hypotension—Lisinopril—systemic scleroderma	0.000648	0.00156	CcSEcCtD
Vancomycin—Dizziness—Captopril—systemic scleroderma	0.000647	0.00156	CcSEcCtD
Vancomycin—Urticaria—Leflunomide—systemic scleroderma	0.000641	0.00155	CcSEcCtD
Vancomycin—Abdominal pain—Leflunomide—systemic scleroderma	0.000638	0.00154	CcSEcCtD
Vancomycin—Body temperature increased—Leflunomide—systemic scleroderma	0.000638	0.00154	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00063	0.00152	CcSEcCtD
Vancomycin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000629	0.00152	CcSEcCtD
Vancomycin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000629	0.00152	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000629	0.00152	CcSEcCtD
Vancomycin—Insomnia—Lisinopril—systemic scleroderma	0.000627	0.00151	CcSEcCtD
Vancomycin—Vomiting—Captopril—systemic scleroderma	0.000622	0.0015	CcSEcCtD
Vancomycin—Dyspnoea—Lisinopril—systemic scleroderma	0.000618	0.00149	CcSEcCtD
Vancomycin—Rash—Captopril—systemic scleroderma	0.000617	0.00149	CcSEcCtD
Vancomycin—Dermatitis—Captopril—systemic scleroderma	0.000616	0.00149	CcSEcCtD
Vancomycin—Headache—Captopril—systemic scleroderma	0.000613	0.00148	CcSEcCtD
Vancomycin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000608	0.00147	CcSEcCtD
Vancomycin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000608	0.00147	CcSEcCtD
Vancomycin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00147	CcSEcCtD
Vancomycin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000603	0.00146	CcSEcCtD
Vancomycin—Eosinophilia—Methotrexate—systemic scleroderma	0.000599	0.00145	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000598	0.00144	CcSEcCtD
Vancomycin—Fatigue—Lisinopril—systemic scleroderma	0.000598	0.00144	CcSEcCtD
Vancomycin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00144	CcSEcCtD
Vancomycin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00144	CcSEcCtD
Vancomycin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000594	0.00143	CcSEcCtD
Vancomycin—Pain—Lisinopril—systemic scleroderma	0.000593	0.00143	CcSEcCtD
Vancomycin—Constipation—Lisinopril—systemic scleroderma	0.000593	0.00143	CcSEcCtD
Vancomycin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00143	CcSEcCtD
Vancomycin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00142	CcSEcCtD
Vancomycin—Bradycardia—Prednisone—systemic scleroderma	0.00059	0.00142	CcSEcCtD
Vancomycin—Nausea—Captopril—systemic scleroderma	0.000581	0.0014	CcSEcCtD
Vancomycin—Asthenia—Leflunomide—systemic scleroderma	0.000579	0.0014	CcSEcCtD
Vancomycin—Pruritus—Leflunomide—systemic scleroderma	0.000571	0.00138	CcSEcCtD
Vancomycin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000569	0.00137	CcSEcCtD
Vancomycin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00137	CcSEcCtD
Vancomycin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000567	0.00137	CcSEcCtD
Vancomycin—Neutropenia—Methotrexate—systemic scleroderma	0.000566	0.00137	CcSEcCtD
Vancomycin—Dizziness—Azathioprine—systemic scleroderma	0.000565	0.00136	CcSEcCtD
Vancomycin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000552	0.00133	CcSEcCtD
Vancomycin—Urticaria—Lisinopril—systemic scleroderma	0.000551	0.00133	CcSEcCtD
Vancomycin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000549	0.00133	CcSEcCtD
Vancomycin—Abdominal pain—Lisinopril—systemic scleroderma	0.000548	0.00132	CcSEcCtD
Vancomycin—Body temperature increased—Lisinopril—systemic scleroderma	0.000548	0.00132	CcSEcCtD
Vancomycin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000544	0.00131	CcSEcCtD
Vancomycin—Vomiting—Azathioprine—systemic scleroderma	0.000543	0.00131	CcSEcCtD
Vancomycin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000541	0.00131	CcSEcCtD
Vancomycin—Infestation NOS—Methotrexate—systemic scleroderma	0.000539	0.0013	CcSEcCtD
Vancomycin—Infestation—Methotrexate—systemic scleroderma	0.000539	0.0013	CcSEcCtD
Vancomycin—Rash—Azathioprine—systemic scleroderma	0.000539	0.0013	CcSEcCtD
Vancomycin—Dermatitis—Azathioprine—systemic scleroderma	0.000538	0.0013	CcSEcCtD
Vancomycin—Flushing—Prednisone—systemic scleroderma	0.000538	0.0013	CcSEcCtD
Vancomycin—Headache—Azathioprine—systemic scleroderma	0.000535	0.00129	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000535	0.00129	CcSEcCtD
Vancomycin—Dizziness—Leflunomide—systemic scleroderma	0.000533	0.00129	CcSEcCtD
Vancomycin—Renal failure—Methotrexate—systemic scleroderma	0.00053	0.00128	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000524	0.00127	CcSEcCtD
Vancomycin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00125	CcSEcCtD
Vancomycin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00125	CcSEcCtD
Vancomycin—Vomiting—Leflunomide—systemic scleroderma	0.000513	0.00124	CcSEcCtD
Vancomycin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000511	0.00123	CcSEcCtD
Vancomycin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000509	0.00123	CcSEcCtD
Vancomycin—Rash—Leflunomide—systemic scleroderma	0.000509	0.00123	CcSEcCtD
Vancomycin—Dermatitis—Leflunomide—systemic scleroderma	0.000508	0.00123	CcSEcCtD
Vancomycin—Nausea—Azathioprine—systemic scleroderma	0.000507	0.00123	CcSEcCtD
Vancomycin—Headache—Leflunomide—systemic scleroderma	0.000505	0.00122	CcSEcCtD
Vancomycin—Erythema—Prednisone—systemic scleroderma	0.000504	0.00122	CcSEcCtD
Vancomycin—Malnutrition—Prednisone—systemic scleroderma	0.000504	0.00122	CcSEcCtD
Vancomycin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000503	0.00122	CcSEcCtD
Vancomycin—Asthenia—Lisinopril—systemic scleroderma	0.000497	0.0012	CcSEcCtD
Vancomycin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000497	0.0012	CcSEcCtD
Vancomycin—Pruritus—Lisinopril—systemic scleroderma	0.00049	0.00118	CcSEcCtD
Vancomycin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000489	0.00118	CcSEcCtD
Vancomycin—Rash—Mycophenolic acid—systemic scleroderma	0.000485	0.00117	CcSEcCtD
Vancomycin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000485	0.00117	CcSEcCtD
Vancomycin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000482	0.00116	CcSEcCtD
Vancomycin—Headache—Mycophenolic acid—systemic scleroderma	0.000482	0.00116	CcSEcCtD
Vancomycin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00048	0.00116	CcSEcCtD
Vancomycin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00048	0.00116	CcSEcCtD
Vancomycin—Nausea—Leflunomide—systemic scleroderma	0.000479	0.00116	CcSEcCtD
Vancomycin—Anaemia—Prednisone—systemic scleroderma	0.000466	0.00113	CcSEcCtD
Vancomycin—Dizziness—Lisinopril—systemic scleroderma	0.000458	0.00111	CcSEcCtD
Vancomycin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000458	0.00111	CcSEcCtD
Vancomycin—Nausea—Mycophenolic acid—systemic scleroderma	0.000457	0.0011	CcSEcCtD
Vancomycin—Vertigo—Prednisone—systemic scleroderma	0.000453	0.00109	CcSEcCtD
Vancomycin—Tinnitus—Methotrexate—systemic scleroderma	0.000451	0.00109	CcSEcCtD
Vancomycin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00108	CcSEcCtD
Vancomycin—Vomiting—Lisinopril—systemic scleroderma	0.000441	0.00106	CcSEcCtD
Vancomycin—Rash—Lisinopril—systemic scleroderma	0.000437	0.00106	CcSEcCtD
Vancomycin—Dermatitis—Lisinopril—systemic scleroderma	0.000437	0.00105	CcSEcCtD
Vancomycin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00105	CcSEcCtD
Vancomycin—Chills—Methotrexate—systemic scleroderma	0.000434	0.00105	CcSEcCtD
Vancomycin—Headache—Lisinopril—systemic scleroderma	0.000434	0.00105	CcSEcCtD
Vancomycin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00104	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000426	0.00103	CcSEcCtD
Vancomycin—Erythema—Methotrexate—systemic scleroderma	0.000421	0.00102	CcSEcCtD
Vancomycin—Malnutrition—Methotrexate—systemic scleroderma	0.000421	0.00102	CcSEcCtD
Vancomycin—Nausea—Lisinopril—systemic scleroderma	0.000412	0.000994	CcSEcCtD
Vancomycin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000412	0.000994	CcSEcCtD
Vancomycin—Infection—Prednisone—systemic scleroderma	0.000409	0.000987	CcSEcCtD
Vancomycin—Back pain—Methotrexate—systemic scleroderma	0.000408	0.000984	CcSEcCtD
Vancomycin—Nervous system disorder—Prednisone—systemic scleroderma	0.000404	0.000975	CcSEcCtD
Vancomycin—Tachycardia—Prednisone—systemic scleroderma	0.000402	0.00097	CcSEcCtD
Vancomycin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00097	CcSEcCtD
Vancomycin—Skin disorder—Prednisone—systemic scleroderma	0.0004	0.000965	CcSEcCtD
Vancomycin—Anaemia—Methotrexate—systemic scleroderma	0.00039	0.000941	CcSEcCtD
Vancomycin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000932	CcSEcCtD
Vancomycin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000925	CcSEcCtD
Vancomycin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000924	CcSEcCtD
Vancomycin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000919	CcSEcCtD
Vancomycin—Vertigo—Methotrexate—systemic scleroderma	0.000379	0.000914	CcSEcCtD
Vancomycin—Insomnia—Prednisone—systemic scleroderma	0.000372	0.000899	CcSEcCtD
Vancomycin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000871	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000356	0.000861	CcSEcCtD
Vancomycin—Fatigue—Prednisone—systemic scleroderma	0.000355	0.000857	CcSEcCtD
Vancomycin—Constipation—Prednisone—systemic scleroderma	0.000352	0.00085	CcSEcCtD
Vancomycin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000344	0.000831	CcSEcCtD
Vancomycin—Infection—Methotrexate—systemic scleroderma	0.000342	0.000825	CcSEcCtD
Vancomycin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000337	0.000815	CcSEcCtD
Vancomycin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000337	0.000813	CcSEcCtD
Vancomycin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000337	0.000813	CcSEcCtD
Vancomycin—Skin disorder—Methotrexate—systemic scleroderma	0.000334	0.000807	CcSEcCtD
Vancomycin—Urticaria—Prednisone—systemic scleroderma	0.000327	0.00079	CcSEcCtD
Vancomycin—Abdominal pain—Prednisone—systemic scleroderma	0.000325	0.000786	CcSEcCtD
Vancomycin—Body temperature increased—Prednisone—systemic scleroderma	0.000325	0.000786	CcSEcCtD
Vancomycin—Hypotension—Methotrexate—systemic scleroderma	0.000321	0.000776	CcSEcCtD
Vancomycin—Insomnia—Methotrexate—systemic scleroderma	0.000311	0.000751	CcSEcCtD
Vancomycin—Dyspnoea—Methotrexate—systemic scleroderma	0.000307	0.000741	CcSEcCtD
Vancomycin—Hypersensitivity—Prednisone—systemic scleroderma	0.000303	0.000732	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000297	0.000717	CcSEcCtD
Vancomycin—Fatigue—Methotrexate—systemic scleroderma	0.000297	0.000716	CcSEcCtD
Vancomycin—Asthenia—Prednisone—systemic scleroderma	0.000295	0.000713	CcSEcCtD
Vancomycin—Pain—Methotrexate—systemic scleroderma	0.000294	0.00071	CcSEcCtD
Vancomycin—Pruritus—Prednisone—systemic scleroderma	0.000291	0.000703	CcSEcCtD
Vancomycin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000281	0.000679	CcSEcCtD
Vancomycin—Urticaria—Methotrexate—systemic scleroderma	0.000273	0.00066	CcSEcCtD
Vancomycin—Dizziness—Prednisone—systemic scleroderma	0.000272	0.000657	CcSEcCtD
Vancomycin—Abdominal pain—Methotrexate—systemic scleroderma	0.000272	0.000657	CcSEcCtD
Vancomycin—Body temperature increased—Methotrexate—systemic scleroderma	0.000272	0.000657	CcSEcCtD
Vancomycin—Vomiting—Prednisone—systemic scleroderma	0.000262	0.000632	CcSEcCtD
Vancomycin—Rash—Prednisone—systemic scleroderma	0.00026	0.000627	CcSEcCtD
Vancomycin—Dermatitis—Prednisone—systemic scleroderma	0.000259	0.000626	CcSEcCtD
Vancomycin—Headache—Prednisone—systemic scleroderma	0.000258	0.000623	CcSEcCtD
Vancomycin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000253	0.000612	CcSEcCtD
Vancomycin—Asthenia—Methotrexate—systemic scleroderma	0.000247	0.000596	CcSEcCtD
Vancomycin—Nausea—Prednisone—systemic scleroderma	0.000244	0.00059	CcSEcCtD
Vancomycin—Pruritus—Methotrexate—systemic scleroderma	0.000243	0.000588	CcSEcCtD
Vancomycin—Dizziness—Methotrexate—systemic scleroderma	0.000227	0.000549	CcSEcCtD
Vancomycin—Vomiting—Methotrexate—systemic scleroderma	0.000219	0.000528	CcSEcCtD
Vancomycin—Rash—Methotrexate—systemic scleroderma	0.000217	0.000524	CcSEcCtD
Vancomycin—Dermatitis—Methotrexate—systemic scleroderma	0.000217	0.000523	CcSEcCtD
Vancomycin—Headache—Methotrexate—systemic scleroderma	0.000215	0.00052	CcSEcCtD
Vancomycin—Nausea—Methotrexate—systemic scleroderma	0.000204	0.000493	CcSEcCtD
